Medical technology company HeraMED Limited (ASX:HMD) has received a significant uplift in interest and demand for its proprietary in-home pregnancy monitoring products HeraBEAT and HeraCARE.
CEO and Cofounder, David Groberman, said the company is responding to the significant increase in demand driven by the global COVID-19 pandemic by optimising its strategy focusing on the most promising opportunities in order to satisfy demand and provide an effective telehealth solution for pregnant women.
Mr Groberman said HMD’s proprietary HeraBEAT foetal heartrate monitor is currently in market and captures data by the expectant mother at home in conjunction with a smartphone application which can then be shared with their doctor.
HMD’s platform, HeraCARE has been developed in collaboration with world leading healthcare providers and leverages artificial intelligence (AI) and its proprietary foetal and maternal heart rate monitor HeraBEAT, to offer medical data collection and prenatal assessment.
In doing so, HeraCARE can accurately monitor the pregnancy, predict potential scenarios and decrease the number of pre and post-natal complications.
The utilisation of HMD’s technology enables real-time data collection that can be shared and inform remote consults with doctors, providing an efficient and effective solution for the management of vulnerable pregnant women and supporting Government advice on social isolation.
The surge in demand for tele-health solutions has been overwhelming and global healthcare systems are struggling to effectively treat patients at a distance and whilst they are working at capacity,” Mr Groberman said.
“This is where our in-home pregnancy management platform can make a significant difference while providing meaningful, genuine medical value.
“Pregnant women have been urged to stay home and avoid all interaction unless absolutely necessary and this brings a range of additional concerns and worries for those women.
“Our mission is to provide those women the tools and support to help alleviate their concerns and ensure they are receiving all the medical assistance they require, in the safety of their own homes.”